Infections in Solid Organ Transplant Recipients

Dear Colleagues,

Infections pose a significant risk to solid organ transplant recipients due to their compromised immune systems resulting from immunosuppressive therapy. Understanding the microbiological aspects of infections in this vulnerable population is crucial for early detection, effective management, and improved patient outcomes.

Solid organ transplant recipients are susceptible to a wide range of infectious agents, including bacteria, viruses, fungi, and parasites. Bacterial infections commonly involve surgical site infections, urinary tract infections, pneumonia, and bloodstream infections. The emergence of drug-resistant bacterial strains further complicates treatment strategies and highlights the importance of appropriate antimicrobial stewardship.

Viruses, such as cytomegalovirus, Epstein-Barr virus, and respiratory viruses, can cause significant morbidity and mortality in transplant recipients. Effective antiviral therapies, prophylaxis, and surveillance measures play a vital role in preventing and managing viral infections. Additionally, emerging viral pathogens, like SARS-CoV-2, have posed new challenges during the COVID-19 pandemic, requiring tailored approaches to protect transplant recipients.

Fungal infections, particularly invasive Candida and Aspergillus infections, present substantial risks to solid organ transplant recipients. Rapid diagnosis, targeted antifungal therapy, and careful monitoring of immunosuppressive regimens are crucial in managing these potentially life-threatening infections.

Parasitic infections, although less common, can occur in transplant recipients, particularly in those with travel histories or exposure to endemic regions. Protozoal and helminthic infections necessitate early identification, prompt treatment, and preventive measures.

Microbiological diagnostic techniques, including molecular assays, serology, and culture-based methods, play a pivotal role in identifying causative agents and guiding appropriate antimicrobial therapy. Surveillance programs and infection prevention protocols implemented in transplant centers are essential for detecting outbreaks and implementing timely interventions.

Efforts to mitigate the risk of infections in solid organ transplant recipients involve a multidisciplinary approach involving microbiologists, infectious disease specialists, transplant surgeons, and immunologists. Ongoing research focusing on the pathogenesis, host-pathogen interactions, and novel diagnostic approaches will continue to refine our understanding of infections in this population and aid in the development of preventive strategies and improved patient care.

Some of the focal points include, but are not limited to, the following:

• management of MDR infections in solid organ transplant patients
• epidemiology and microbiology of infections in solid organ transplant patients
• impact of MDR germ infections in solid organ transplant patients
• new therapeutic options in solid organ transplant patients

Reviews, original research, and communications will be welcome. 

Dr. Biagio Pinchera
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.